Bohai Pharmaceuticals Group (BOPH) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BOPH Annual Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Bohai Pharmaceuticals Group manages assets, liabilities, and equity through different cycles.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2014)
(Jun 30 2014) (Mar 31 2014) (Dec 31 2013) (Sep 30 2013)
Assets
Cash & cash equivalent27.14
Restricted Cash and Cash Equivalents, Current22.38
Cash & Short-term Investments49.00
Accounts receivable37.69
Inventories5.24
Prepaid Expense And Other Assets Current10.37
Total Current Assets102.82
Equipment/Property/Plant Net20.94
Goodwill net5.22
Intangible Assets51.59
Other Assets, Noncurrent23.09
Total Assets203.66
Liabilities
Accounts Payable, Current AC6.61
Accrued Liabilities, Current AC12.41
Short-term Debt DE14.87
Other Liabilities, Current19.55
Taxes Payable, Current, Total5.31
Total Current Liabilities48.77
Long-term debt19.50
Total Long-term Debt19.50
Deferred Tax Liabilities, Net, Noncurrent LI8.12
Total Liabilities62.10
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock27.39
Retained Earnings / Accumulated Deficit105.99
Other Equity8.16
Common Stockholder's Equity141.56
Total Stockholder's Equity141.56
Liabilities & Stockholder's Equity203.66
4 historic quarters locked

Sign in to unlock the full Bohai Pharmaceuticals Group balance sheet history.

About BOPH Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.